Genetic Technologies Limited
GNTLF
$0.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.44M | 3.73M | 5.03M | 5.32M | 5.65M |
| Total Other Revenue | 993.60K | 1.16M | 1.32M | 1.24M | 1.16M |
| Total Revenue | 3.43M | 3.60M | 3.76M | 3.97M | 4.23M |
| Cost of Revenue | 1.32M | 1.32M | 1.32M | 1.39M | 1.48M |
| Gross Profit | 2.11M | 2.28M | 2.44M | 2.58M | 2.75M |
| SG&A Expenses | 4.69M | 4.88M | 5.06M | 4.87M | 4.72M |
| Depreciation & Amortization | 209.80K | 239.30K | 268.50K | 300.40K | 335.20K |
| Other Operating Expenses | 1.47M | 1.68M | 1.88M | 1.95M | 2.04M |
| Total Operating Expenses | 7.93M | 8.36M | 8.77M | 8.87M | 9.06M |
| Operating Income | -4.50M | -4.76M | -5.01M | -4.90M | -4.83M |
| Income Before Tax | -5.70M | -5.40M | -5.07M | -5.33M | -5.64M |
| Income Tax Expenses | -- | -- | -- | -3.40K | -6.90K |
| Earnings from Continuing Operations | -5.70 | -5.40 | -5.07 | -5.33 | -5.64 |
| Earnings from Discontinued Operations | -683.10K | -1.75M | -2.81M | -2.81M | -2.81M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.39M | -7.15M | -7.88M | -8.14M | -8.44M |
| EBIT | -4.50M | -4.76M | -5.01M | -4.90M | -4.83M |
| EBITDA | -4.29M | -4.52M | -4.74M | -4.70M | -4.70M |
| EPS Basic | -0.04 | -0.05 | -0.06 | -0.07 | -0.07 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
| EPS Diluted | -0.04 | -0.05 | -0.06 | -0.07 | -0.07 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
| Average Basic Shares Outstanding | 586.57M | 557.72M | 528.87M | 490.27M | 451.68M |
| Average Diluted Shares Outstanding | 586.57M | 557.72M | 528.87M | 490.27M | 451.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |